Ronald Peck
2021
In 2021, Ronald Peck earned a total compensation of $4.3M as Chief Medical Officer at ARVINAS, a 47% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $264,700 |
|---|---|
| Option Awards | $3,572,466 |
| Salary | $435,630 |
| Other | $11,600 |
| Total | $4,284,396 |
Peck received $3.6M in option awards, accounting for 83% of the total pay in 2021.
Peck also received $264.7K in non-equity incentive plan, $435.6K in salary and $11.6K in other compensation.
Rankings
In 2021, Ronald Peck's compensation ranked 3,102nd out of 12,415 executives tracked by ExecPay. In other words, Peck earned more than 75.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,102 out of 12,415 | 75th |
Division Manufacturing | 1,244 out of 5,508 | 77th |
Major group Chemicals And Allied Products | 501 out of 2,378 | 79th |
Industry group Drugs | 443 out of 2,099 | 79th |
Industry Pharmaceutical Preparations | 303 out of 1,549 | 80th |
Source: SEC filing on April 27, 2022.
Peck's colleagues
We found three more compensation records of executives who worked with Ronald Peck at ARVINAS in 2021.